HTY yields 12.83% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 5
Combined, HTY + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HTY + MRK for your $10,000?
John Hancock Investments - John Hancock Tax-Advantaged Global Shareholder Yield Fund is a closed ended equity mutual fund launched and managed by John Hancock Investment Management LLC. It is co-managed by Analytic Investors, LLC and Epoch Investment Partners, Inc. The fund invests in the public equity markets across the globe. It seeks to invest in stocks of companies operating in utilities, telecommunication services, consumer staples, financials, industrials, energy, healthcare, information technology, consumer discretionary, real estate and materials sectors. The fund primarily invests in dividend paying stocks of companies. It invests in stocks of companies across diversified market capitalizations. The fund employs fundamental analysis with a bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against the MSCI World Index. John Hancock Investments - John Hancock Tax-Advantaged Global Shareholder Yield Fund was formed on September 26, 2007 and is domiciled in the United States.
Full HTY Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.